Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition.
The prediction of biological activity of a chemical compound from its structural features plays an important role in drug design. In this paper, we discuss the quantitative structure activity relationship (QSAR) prediction models developed on a dataset of 170 HIV protease enzyme inhibitors. Various chemical descriptors that encode hydrophobic, topological, geometrical and electronic properties are calculated to represent the structures of the molecules in the dataset. We use the hybrid-GA (genetic algorithm) optimization technique for descriptor space reduction. The linear multiple regression analysis (MLR), correlation-based feature selection (CFS), non-linear decision tree (DT), and artificial neural network (ANN) approaches are used as fitness functions. The selected descriptors represent the overall descriptor space and account well for the binding nature of the considered dataset. These selected features are also human interpretable and can be used to explain the interactions between a drug molecule and its receptor protein (HIV protease). The selected descriptors are then used for developing the QSAR prediction models by using the MLR, DT and ANN approaches. These models are discussed, analyzed and compared to validate and test their performance for this dataset. All three approaches yield the QSAR models with good prediction performance. The models developed by DT and ANN are comparable and have better prediction than the MLR model. For ANN model, weight analysis is carried out to analyze the role of various descriptors in activity prediction. All the prediction models point towards the involvement of hydrophobic interactions. These models can be useful for predicting the biological activity of new untested HIV protease inhibitors and virtual screening for identifying new lead compounds.
Reddy
A Srinivas
AS
Department of Biomedical Engineering, University of California-Davis, Davis, CA 95616-5294, USA. sralla@ucdavis.edu
Kumar
Sunil
S
Garg
Rajni
R
D000465:Algorithms; D015195:Drug Design; D017320:HIV Protease Inhibitors / Q000737:chemistry*; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D011725:Pyridines / Q000737:chemistry*; D011753:Pyrones / Q000737:chemistry*; D021281:Quantitative Structure-Activity Relationship; D013449:Sulfonamides
D017320:HIV Protease Inhibitors; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; C107201:tipranavir
IEEE Trans Neural Netw. 2008 May;19(5):836-44
18467212
J Chem Inf Comput Sci. 2004 Mar-Apr;44(2):716-26
15032554
Expert Opin Emerg Drugs. 2006 May;11(2):217-30
16634698
J Med Chem. 2004 Apr 22;47(9):2356-64
15084134
J Chem Inf Comput Sci. 2003 Jul-Aug;43(4):1200-7
12870912
J Chem Inf Model. 2008 Jan;48(1):213-9
18163603
Ann Chim. 2007 Jan-Feb;97(1-2):69-83
17822265
IEEE Trans Neural Netw. 2005 Jan;16(1):263-74
15732405
J Chem Inf Model. 2005 Jul-Aug;45(4):1109-21
16045306
Science. 1986 May 9;232(4751):697
3008335
Top HIV Med. 2008 Dec;16(5):138-45
19106428
IEEE/ACM Trans Comput Biol Bioinform. 2007 Jul-Sep;4(3):476-484
17666767
J Infect. 2008 Jul;57(1):1-10
18556070
Chem Rev. 1999 Dec 8;99(12):3525-3602
11849030
Bioinformatics. 2003 Jan;19(1):98-107
12499299
J Chem Inf Comput Sci. 2004 Jul-Aug;44(4):1257-66
15272833
J Chem Inf Comput Sci. 2000 May;40(3):659-67
10850771
Chem Rev. 1996 Dec 19;96(8):3147-3176
11848856
Bioorg Med Chem Lett. 2005 Aug 15;15(16):3767-70
15993582
Curr Med Chem. 2003 Sep;10(17):1679-88
12871116
Bioorg Med Chem. 2005 Jun 2;13(12):4078-84
15911321
Neural Netw. 1999 Jan;12(1):145-151
12662723
Curr Top Med Chem. 2006;6(1):31-9
16454756
Bioinformatics. 2004 Oct 12;20(15):2479-81
15073010
Bioorg Med Chem Lett. 2006 Apr 1;16(7):1869-73
16480871
J Infect Dis. 2003 Sep 1;188(5):653-60
12934180
Chem Res Toxicol. 2008 Dec;21(12):2229-36
19548346
Mini Rev Med Chem. 2008 Mar;8(3):213-21
18336341
Biosystems. 2003 Nov;72(1-2):149-58
14642664
Curr Drug Discov Technol. 2007 Oct;4(3):141-9
17985997
Mini Rev Med Chem. 2007 Nov;7(11):1097-107
18045213